PT  - JOURNAL ARTICLE
AU  - Albert Stuart Reece
AU  - Gary Kenneth Hulse
TI  - Epidemiological Association of Cannabinoid- and Drug- Exposures and Sociodemographic Factors with Limb Reduction Defects Across USA 1989-2016: A Geotemporospatial and Causal Inference Study
AID  - 10.1101/2020.09.01.20186163
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.01.20186163
4099  - http://medrxiv.org/content/early/2020/09/03/2020.09.01.20186163.short
4100  - http://medrxiv.org/content/early/2020/09/03/2020.09.01.20186163.full
AB  - Reports of major limb defects after prenatal cannabis exposure (PCE) in animals and of human populations in Hawaii, Europe and Australia raise the question of whether the increasing use of cannabis in USA might be spatiotemporally associated with limb reduction rates (LRR) across USA. Geotemporospatial analysis conducted in R. LRR was significantly associated with cannabis use and THC potency and demonstrated prominent cannabis-use quintile effects. In final lagged geospatial models interactive terms including cannabinoids were highly significant and robust to adjustment. States in which cannabis was not legalized had a lower LRR (4.28 v 5.01 /10,000 live births, relative risk reduction = −0.15, (95%C.I. −0.25, −0.02), P=0.021). 37-63% of cases are estimated to not be born alive; their inclusion strengthened these associations. Causal inference studies using inverse probabilty-weighted robust regression and e-values supported causal epidemiological pathways. Findings apply to several cannabinoids, are consistent with pathophysiological and causal mechanisms, are exacerbated by cannabis legalization and demonstrate dose-related intergenerational sequaelae.HighlightsLimb reduction rates (LRR) were associated with cannabis use, and THC potencyThese relationships were robust to adjustment for ethic and economic covariatesThey were maintained at geospatiotemporal regressionLRR elevated as stillborn and aborted cases were consideredCriteria of causality was fulfilledCompeting Interest StatementThe authors have declared no competing interest.Funding StatementNilAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics. This research was approved by the Human Ethics Research Committee of the University of Western Australia June 7th 2019, (RA/4/20/4724).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData Availability Statement. Key data including software code in R and a Data Dictionary key has been made available in the Mendeley data repository at this URL: http://dx.doi.org/10.17632/gtk7w24yvs.1. http://dx.doi.org/10.17632/gtk7w24yvs.1